Effect of Genetic Testing on Diagnosing Gastrointestinal Pediatric Patients with Previously Undiagnosed Diseases

References

• Wojcik MH, Schwartz TS, Yamin I, et al. Genetic disorders and mortality in infancy and early childhood: delayed diagnoses and missed opportunities HHS public access author manuscript. Gene Med. 2018;20. 254. doi:10.1038/gim.2018.17
   Web of Science ®Google Scholar
• Yoon PW. Contribution of birth defects and genetic diseases to pediatric hospitalizations: A population-based study. Arch Pediatr Adolesc Med. 1997;151(11):1096–1103. doi:10.1001/archpedi.1997.02170480026004
   PubMed Web of Science ®Google Scholar
• Tan TY, Dillon OJ, Stark Z, et al. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. JAMA Pediatrics. 2017;171(9):855. doi:10.1001/jamapediatrics.2017.1755
   PubMed Web of Science ®Google Scholar
• Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med. 2011;13(3):255–262. doi:10.1097/GIM.0b013e3182088158
   PubMed Web of Science ®Google Scholar
• Goh G, Choi M. Application of Whole Exome Sequencing to Identify Disease-Causing Variants in Inherited Human Diseases. Genomics & Informatics. 2012;10(4):214. doi:10.5808/gi.2012.10.4.214
   Google Scholar
• Bras J, Singleton A. Exome sequencing in Parkinson’s disease. Clin Genet. 2011;80(2):104–109. doi:10.1111/j.1399-0004.2011.01722.x
   Web of Science ®Google Scholar
• Sassi C, Guerreiro R, Gibbs R, et al. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer’s disease. Neurobiol Aging. 2014;35(10):2422.e13-2422.e16. doi:10.1016/j.neurobiolaging.2014.04.026
   Web of Science ®Google Scholar
• Azab B, Dardas Z, Rabab’h O, et al. Enteric anendocrinosis attributable to a novel Neurogenin-3 variant. European Journal of Medical Genetics. 2020;63(9):103981. doi:10.1016/j.ejmg.2020.103981
   Web of Science ®Google Scholar
• Warr A, Robert C, Hume D, Archibald A, Deeb N, Watson M. Exome sequencing: current and future perspectives. G3 Genes Genomes Genet. 2015;5(8):1543–1550. doi:10.1534/g3.115.018564
   Web of Science ®Google Scholar
• Sawyer SL, Hartley T, Dyment DA, et al. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care. Clin Genet. 2016;89(3):275–284. doi:10.1111/cge.12654
   PubMed Web of Science ®Google Scholar
• Mussap M, Zaffanello M, Fanos V. Metabolomics: a challenge for detecting and monitoring inborn errors of metabolism. Ann Transl Med. 2018;6(17):338. doi:10.21037/atm.2018.09.18
   PubMed Web of Science ®Google Scholar
• Champion MP. An approach to the diagnosis of inherited metabolic disease. Arch Dis Child Educ Pract Ed. 2010;95(2):40–46. doi:10.1136/adc.2008.151183
   Web of Science ®Google Scholar
• Sebastio G, Sperandeo MP, Andria G. Lysinuric protein intolerance: reviewing concepts on a multisystem disease. Am J Med Genet Part C Semin Med Genet. 2011;157(1):54–62. doi:10.1002/ajmg.c.30287
   Web of Science ®Google Scholar
• Sperandeo MP, Andria G, Sebastio G. Lysinuric protein intolerance: update and extended mutation analysis of theSLC7A7 gene. Hum Mutat. 2008;29(1):14–21. doi:10.1002/humu.20589
   Web of Science ®Google Scholar
• Sperandeo MP, Paladino S, Maiuri L, et al. A y+LAT-1 mutant protein interferes with y+LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance. Eur J Hum Genet. 2005;13(5):628–634. doi:10.1038/sj.ejhg.5201376
   Web of Science ®Google Scholar
• Posey JE, Burrage LC, Miller MJ, et al. Lysinuric protein intolerance presenting with multiple fractures. Mol Genet Metab Rep. 2014;1(1):176–183. doi:10.1016/j.ymgmr.2014.03.004
   Google Scholar
• Cimbalistienè L, Lehnert W, Huoponen K, Kučinskas V. First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis. J Appl Genet. 2007;48(3):277–280. doi:10.1007/bf03195224
   Web of Science ®Google Scholar
• Ravenscroft G, Pannell S, O’Grady G, et al. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction. Neurogastroenterol Motil. 2018;30(9):e13371. doi:10.1111/nmo.13371
   Web of Science ®Google Scholar
• Wangler MF, Beaudet AL. ACTG2-Related Disorders. University of Washington, Seattle; 1993. http://www.ncbi.nlm.nih.gov/pubmed/26072522. Accessed March 14, 2020..
   Google Scholar
• Sticova E, Jirsa M, Pawłowska J. New Insights in Genetic Cholestasis: from Molecular Mechanisms to Clinical Implications. Canadian Journal of Gastroenterology and Hepatology. 2018;2018:1–12. doi:10.1155/2018/2313675
   Web of Science ®Google Scholar
• Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. Brain-derived neurotrophic factor: A bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014;8(DEC). doi:10.3389/fncel.2014.00430
   Web of Science ®Google Scholar
• Nicastro E, Di Giorgio A, Marchetti D, et al. Diagnostic Yield of an Algorithm for Neonatal and Infantile Cholestasis Integrating Next-Generation Sequencing. J Pediatr. 2019;211(54):54–62.e4. doi:10.1016/j.jpeds.2019.04.016
   Web of Science ®Google Scholar
• Nicastro E, D’Antiga L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transplant. 2018;24(2):282–293. doi:10.1002/lt.24964
   Web of Science ®Google Scholar
• Huang HY, Zhou H, Wang H, Chen YX, Fang F. Novel mutations in the 3β-hydroxy-Δ5-C27-steroid dehydrogenase gene (HSD3B7) in a patient with neonatal cholestasis. Chin Med J. 2016;129(1):98–100. doi:10.4103/0366-6999.172603
   Web of Science ®Google Scholar
• Cheng JB, Jacquemin E, Gerhardt M, et al. Molecular genetics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency in 16 patients with loss of bile acid synthesis and liver disease. J Clin Endocrinol Metab. 2003;88(4):1833–1841. doi:10.1210/jc.2002-021580
   Web of Science ®Google Scholar
• Yuste-Checa P, Vega AI, Martín-Higueras C, et al. DPAGT1-CDG: functional analysis of disease-causing pathogenic mutations and role of endoplasmic reticulum stress. Lewin AS, ed. PLoS One. 2017;12(6):e0179456. doi:10.1371/journal.pone.0179456
   Web of Science ®Google Scholar
• Carrera IA, Matthijs G, Perez B, Cerdá CP. DPAGT1-CDG: report of a patient with fetal hypokinesia phenotype. Am J Med Genet Part A. 2012;158A(8):2027–2030. doi:10.1002/ajmg.a.35472
   Web of Science ®Google Scholar
• Imtiaz F, Al-Mostafa A, Al-Hassnan ZN. Further delineation of the phenotype of congenital disorder of glycosylation DPAGT1-CDG (CDG-Ij) identified by homozygosity mapping. JIMD Rep. 2012;2:107–111. doi:10.1007/8904_2011_57
   Google Scholar
• Kumar P, Radhakrishnan J, Chowdhary MA, Giampietro PF. Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department. Mayo Clin Proc. 2001;76(8):777–783. doi:10.1016/S0025-6196(11)63220-5
   PubMed Web of Science ®Google Scholar
• Stark Z, Tan TY, Chong B, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet Med. 2016;18(11):1090–1096. doi:10.1038/gim.2016.1
   PubMed Web of Science ®Google Scholar